|Disease Group:||Lymphoma; Myeloma|
|Phase of Study:||Phase I/Phase II|
|Treatment Location:||Only at MDACC|
|Estimated Length of Stay in Houston:||30 days post transplant, and will include inpatient and out patient care during |
this time period.
|Return Visit:||Study will terminate on transplant day +100. Patients will subsequently |
monitored at the discretion of their physicians.
|Home Care:||IV fluids, etc. as determined by patient's clinical status.|